Search Within

Sarah Marie Cheal

Formats
  1. Journal Article (30)
  2. Meeting Abstract (19)
  3. Review (1)
Groups
  1. GSK Faculty (50)
  2. Radiology, Department of (50)
  3. Sloan Kettering Institute Postdocs (50)
  4. Molecular Imaging and Therapy Service (47)
  5. Molecular Pharmacology and Chemistry Program Faculty (47)
  6. Sloan Kettering Institute Faculty (47)

More Groups

People
  1. Steven Larson (45)
  2. Nai-Kong Cheung (29)
  3. Hong-Fen Guo (24)
  4. Darren Veach (23)
  5. Blesida Punzalan (21)
  6. Hong Xu (21)

More People

Years
  1. 2025 (2)
  2. 2024 (2)
  3. 2023 (2)
  4. 2022 (6)
  5. 2021 (4)
  6. 2020 (7)

More Years

Publications
  1. Journal of Nuclear Medicine (16)
  2. Theranostics (5)
  3. Bioconjugate Chemistry (4)
  4. European Journal of Nuclear Medicine and Molecular Imaging (4)
  5. Cancer Research (3)
  6. Journal of Clinical Oncology (3)

More Publications

Publishers
  1. Society of Nuclear Medicine (16)
  2. American Chemical Society (8)
  3. American Association for Cancer Research (7)
  4. Ivyspring International Publisher (5)
  5. Springer (5)
  6. American Society of Clinical Oncology (3)

More Publishers

Results (50)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Comparative efficacy and toxicity of (177)Lu- vs (90)Y-theranostic anti-HER2/anti-DOTA(metal) pretargeted radioimmunotherapy (anti-HER2 DOTA-PRIT) of HER2-expressing breast cancer xenografts with curative intent
    Meeting Abstract

    Cheal, S.; Fung, E.; Xu, H.; Guo, H. F.; Patel, M.; Bell, M.; Kalidindi, T.; Punzalan, B.; Zanzonico, P.; Wittrup, K.; more...
    Journal of Nuclear Medicine (2017)

    Fulltext@MSK | Save
  • First-in-human imaging with (89)Zr-Df-IAB2M Anti-PSMA minibody in patients with metastatic prostate cancer: Pharmacokinetics, biodistribution, dosimetry, and lesion uptake
    Journal Article

    Pandit-Taskar, N.; O'Donoghue, J. A.; Ruan, S.; Lyashchenko, S. K.; Carrasquillo, J. A.; Heller, G.; Martinez, D. F.; Cheal, S. M.; Lewis, J. S.; Fleisher, M.; more...
    Journal of Nuclear Medicine (2016)

    Fulltext@MSK | Save
  • Theranostic pretargeted radioimmunotherapy of colorectal cancer xenografts in mice using picomolar affinity (86)Y- or (177)Lu-DOTA-Bn binding scFv C825/GPA33 IgG bispecific immunoconjugates
    Journal Article

    Cheal, S. M.; Xu, H.; Lee, S. G.; Guo, H. F.; Punzalan, B.; Chalasani, S.; Fung, E.; Jungbluth, A.; Zanzonico, P.; Carrasquillo, J.; more...
    European Journal of Nuclear Medicine and Molecular Imaging (2016)

    Fulltext@MSK | Save
  • Targeting of radiolabeled J591 antibody to PSMA-expressing tumors: Optimization of imaging and therapy based on non-linear compartmental modeling
    Journal Article

    Fung, E. K.; Cheal, S. M.; Fareedy, S. B.; Punzalan, B.; Beylergil, V.; Amir, J.; Chalasani, S.; Weber, W. A.; Spratt, D. E.; Veach, D. R.; more...
    EJNMMI Research (2016)

    Fulltext@MSK | Save
  • A phase I/II study for analytic validation of 89Zr-J591 immunoPET as a molecular imaging agent for metastatic prostate cancer
    Journal Article

    Pandit-Taskar, N.; O'Donoghue, J. A.; Durack, J. C.; Lyashchenko, S. K.; Cheal, S. M.; Beylergil, V.; Lefkowitz, R. A.; Carrasquillo, J. A.; Martinez, D. F.; Fung, A. M.; more...
    Clinical Cancer Research (2015)

    Fulltext@MSK | Save
  • Humanized affinity-matured monoclonal antibody 8H9 has potent antitumor activity and binds to FG loop of tumor antigen B7-H3
    Journal Article

    Ahmed, M.; Cheng, M.; Zhao, Q.; Goldgur, Y.; Cheal, S. M.; Guo, H. F. ; Larson, S. M.; Cheung, N. K. V.
    Journal of Biological Chemistry (2015)

    Fulltext@MSK | Save
  • Tumor-directed PET imaging of metastases in metastatic castration-resistant prostate cancer (mCRPC) using Zr-89 labeled antiprostate-specific membrane antigen (PSMA) antibody J591
    Meeting Abstract

    Feldman, J. L.; Morris, M. J.; Martinez, D. F.; Tagawa, S. T.; Nanus, D. M.; Solomon, S. B.; Carrasquillo, J. A.; Reuter, V. E.; Lewis, J. S.; O'Donoghue, J. A.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Tumor-directed PET imaging of metastases in metastatic castration-resistant prostate cancer (mCRPC) using Zr-89 labeled antiprostate-specific membrane antigen (PSMA) antibody J591
    Meeting Abstract

    Feldman, J. L.; Morris, M. J.; Tagawa, S. T.; Nanus, D. M.; Solomon, S. B.; Carrasquillo, J. A.; Reuter, V. E.; Lewis, J. S.; O'Donoghue, J. A.; Martinez, D. F.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Initial PET imaging and pharmacokinetic results from a Phase I/II study of Zr-89-labeled anti-STEAP1 antibody in metastatic castrate-resistant prostate cancer (mCRPC) patients
    Meeting Abstract

    Carrasquillo, J. A.; Danila, D. C.; Beylergil, V.; O'Donoghue, J. A.; Cheal, S. M.; Ruan, S. T.; Pandit-Taskar, N.; Fox, J. J.; Fleming, S. E.; Zanzonico, P. B.; more...
    Cancer Research (2014)

    Fulltext@MSK | Save
  • 89Zr-huJ591 immuno-PET imaging in patients with advanced metastatic prostate cancer
    Journal Article

    Pandit-Taskar, N.; O'Donoghue, J. A.; Beylergil, V.; Lyashchenko, S.; Ruan, S.; Solomon, S. B.; Durack, J. C.; Carrasquillo, J. A.; Lefkowitz, R. A.; Gonen, M.; more...
    European Journal of Nuclear Medicine and Molecular Imaging (2014)

    Fulltext@MSK | Save